COVID-19 Vaccination in Liver Cirrhosis: Safety and Immune and Clinical Responses.

GE Port J Gastroenterol · 2024 · PMC11444661 · PMID 39360169

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

Another study in patients vaccinated with BNT162b2 (70.3%), mRNA-1273 (18.9%), or ChAdOx1nCoV-19 (10.8%) [ 15 ] reported a nonsignificant trend to lower IgG antibody levels in patients with cirrhosis or advanced liver fibrosis (F3–F4) compared with healthy controls, 2 weeks and 6 months after vaccination.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.